News SciSparc Ltd.

Equities

SPRC

IL0010951403

Delayed Nasdaq Other stock markets 15:35:37 16/05/2024 BST			5-day change	1st Jan Change
1.225 ^USD	+2.08%		-4.30%	-74.90%

04-11	SciSparc Ltd. signed a merger agreement to acquire remaining stake in Automax Motors Ltd.	CI
04-01	SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SciSparc to Acquire AutoMax	04-11	GL
SciSparc Ltd. signed a merger agreement to acquire remaining stake in Automax Motors Ltd.	04-10	CI
SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research	03-21	GL
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada	03-18	GL
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada	03-18	AQ
SciSparc Ltd. Receives Another Patent, Strengthening its Core Technology in Canada	03-18	CI
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial	03-14	GL
SciSparc Ltd. Announces Successfully Dosed the First Patient in Its SCI-210 Clinical Trial At the Soroka Medical Center for Pediatric Patients	03-14	CI
SciSparc : MitoCareX Update - Form 6-K	03-13	PU
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure	03-12	GL
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure	03-12	AQ
Top Premarket Gainers	03-08	MT
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder	03-08	GL
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder	03-08	AQ
SciSparc Ltd. Announces Enrollment of First Patient for Its Clinical Trial for Children with Autism Spectrum Disorder	03-08	CI
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe	03-07	GL
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe	03-07	AQ
Scisparc Ltd. Granted Patent for Core Technology in Multiple Jurisdictions in Europe	03-07	CI
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology	03-06	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SciSparc Ltd.

Equities

SPRC

IL0010951403

Summary

Filters